Deciphering stringent response proteins and toxin-antitoxin systems in the arms race between bacteria and phages

This project aims to identify phage proteins that target bacterial defense systems to advance phage therapy and improve bioremediation by studying Pseudomonas putida interactions.

Subsidie
€ 1.499.250
2024

Projectdetails

Introduction

Bacteriophages, viruses of bacteria, are the most abundant life form on Earth. The prospect of using them in the fight against pathogenic bacteria has long been recognized, but their very high specificity and unpredictable reproduction limits their use in medicine.

Background

The mechanisms phages use to fight bacteria are attractive candidates for the development of novel antimicrobial applications, but are still very poorly understood. Indirect evidence exists of toxin-antitoxin systems (TAS) and stringent response involvement in phage defense. The constant co-evolution of phages and bacteria suggests that phages have a way of overcoming all of the wide variety of bacterial defense systems. Yet, no direct phage mechanisms targeting bacterial stringent response have been identified.

Hypothesis

We hypothesize that as the bacterial toxin-antitoxin systems and stringent response play a part in the arms race between bacteria and phages, we can provide direct molecular evidence and identify phage proteins involved in these interactions by:

  1. Creating and characterizing, morphologically and molecularly, a novel library of phages infecting Pseudomonas putida PaW85.
  2. Uncovering the stringent response- and TAS-mediated phenotypic effects and their molecular mechanisms on P. putida phage tolerance.
  3. Discovering and characterizing, functionally and structurally, the anti-TAS and anti-stringent response phage effectors.
  4. Determining the toxicity and specificity of the identified phage-derived toxins by testing them on different bacterial species.

Significance

This study will bridge several gaps in the phage-bacteria interaction research, advance the research of phage-tolerant bioremediation strains, and provide crucial basic knowledge that can lead to the development of novel, efficient phage therapy solutions that target bacterial stress mechanisms.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.250
Totale projectbegroting€ 1.499.250

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • TARTU ULIKOOLpenvoerder

Land(en)

Estonia

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Phage infection of bacterial biofilm

This project aims to characterize the dynamics of Herelleviridae phage phi812 in Staphylococcus aureus biofilms to enhance phage therapy effectiveness against antibiotic-resistant infections.

€ 1.992.976
ERC COG

Exploiting plasmid–bacteria interactions to fight the evolution of antimicrobial resistance

PLAS-FIGHTER aims to develop innovative strategies against plasmid-mediated antimicrobial resistance by exploring plasmid-induced physiological effects in bacteria using advanced screening and ecological models.

€ 1.999.573
ERC ADG

Breaking resistance of pathogenic bacteria by chemical dysregulation

The project aims to combat antibiotic-resistant bacteria by developing innovative small molecules that dysregulate bacterial physiology through a three-tiered chemical strategy.

€ 2.499.785
ERC POC

All-in-one supramolecular approach as an innovative anti-infectious strategy

PATHO-LEGO aims to develop hybrid molecules that simultaneously block Pseudomonas aeruginosa adhesion and recruit natural antibodies to enhance immune clearance of resistant strains.

€ 150.000